Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Advanced Human Imaging Ltd. ( (AU:AHI) ) has provided an update.
Advanced Health Intelligence Ltd has announced several strategic developments for the quarter ending December 31, 2024, including partnerships with Vitall in Canada and Unisure in the UK. These partnerships aim to expand the use of AHI’s Digital Health Assessment tools in health screening and insurance underwriting, respectively. Additionally, AHI has secured USD$4 million in funding from KOR Investments LLC to support its operations and plans to raise a total of AUD$10 million. Despite technical issues delaying the release of its 2024 Annual Report, AHI is working towards resolving these matters to facilitate the reinstatement of its securities on the ASX. The company’s initiatives highlight its commitment to enhancing health assessment technologies and improving industry positioning in the health and insurance sectors.
More about Advanced Human Imaging Ltd.
Advanced Health Intelligence Ltd (AHI) operates in the health technology industry, specializing in digital health assessments and biometric health solutions. The company focuses on developing applications and technologies that leverage digital biomarkers to support health risk assessments and medical treatment management. AHI is expanding its market presence through partnerships and innovations in health assessment and insurance underwriting.
YTD Price Performance: 6.25%
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$20.52M
Learn more about AHI stock on TipRanks’ Stock Analysis page.
